Analysis of Pharmaceutical Business Industry

1
Pharmaceutical Business Confidence Report Q1 2014
Published DateJanuary 2014
No. of Pages 59
Price Single User US 1990 Corporate
User US 5850
2
New Market Research Report on Pharmaceutical
Business Confidence Report Q1 2014 added to
ReportsnReports.com
Order report Challenges Pharmaceutical Business
Confidence Report Q1 2014 by calling
ReportsnReports.com at 1 888 391 5441 OR send an
email on sales_at_reportsandreports.com with
Pharmaceutical Business Confidence Report Q1 2014
in subject line and your contact details.
Synopsis Pharmaceutical Business Confidence
Report Q1 2014 is a new report by Kable that
analyzes pharmaceutical industry executives
views on the global economy, expectations on
customer confidence, supplier prices, key
business concerns, and how executives future
investments are set to change in Q1 2014. This
report also gives you access to regional analysis
of industry outlook, industry and company growth
prospects, future opportunities, staff hiring,
and sales performance. Apart from providing
access to the opinions and strategies of global
pharmaceutical industry executives, it also
examines their actions surrounding business
priorities, threats and opportunities, and future
investment areas over the next six months.
Moreover, this report provides a comparative
analysis of survey results with Q4 2013 wherever
applicable. Introduction and Landscape Why was
the report written? This report is the result of
an extensive survey drawn from Kables exclusive
panel of leading global pharmaceutical industry
executives. The report analyzes current economic
conditions prevailing across the globe and their
impact on the pharmaceutical industry, and
forecasts company and industry growth prospects
over the next six months. Furthermore, it
provides information about the impact of customer
confidence, supplier prices, and staff headcount
likely to affect the investment decisions of the
industry over the next six months. Additionally,
this report tracks the change in executives
perceptions during the last three months, by
providing a comparative analysis of survey
results with the previous quarter.
3
Pharmaceutical Business Confidence Report Q1 2014
What is the current market landscape and what is
changing? Overall, 74 and 60 of global
pharmaceutical industry executives are optimistic
about the future growth prospects of both their
company and the industry, respectively, over the
next six months. Optimism towards company and
industry growth prospects has improved by eight
and ten percentage points, respectively, in Q1
2014, compared to Q4 2013 results. Inquiry Before
Buying on this Report _at_ http//www.reportsnreports
.com/contacts/inquirybeforebuy.aspx?name274168
. What are the key drivers behind recent market
changes? Optimism towards industry and company
growth is driven by the improving global economic
conditions, investments in emerging markets, and
the introduction of new products in the
market. What makes this report unique and
essential to read? Pharmaceutical Business
Confidence Report Q1 2014 is a new report by
Kable that analyzes the industry sentiments
globally on the latest economic and customer
issues and their impact upon investment decisions
and growth prospects within the pharmaceutical
industry. This report also examines the executive
opinion about the current and future state of the
economy and its retrospective effect on the
industry. Furthermore, it analyzes the likely
effect of supplier price changes, sales
performance, and staff headcount within the
industry over the next six months. In addition,
it provides an overview of the key priorities,
threats, and opportunities for the global
pharmaceutical industry over the next six months.
Furthermore, it also tracks the change in
industry executives thought process, by
providing a comparative analysis of survey
results with Q4 2013, wherever applicable.
Browse more research reports on
Pharmaceuticals_at_ http//www.reportsnreports.com/ma
rket-research/pharmaceuticals/ .
4
Pharmaceutical Business Confidence Report Q1 2014
Key Features and Benefits Project industry trends
and industry growth expectations in the next six
months, and understand business confidence to
make informed business decisions. The report
drives revenues by understanding future product
investment areas and key growth regions. Readers
will be provided with a clear uncovering of key
challenges and opportunities, and identify the
key priorities likely to affect growth prospects
of the industry. The report clearly forecasts the
change in supplier prices for various products,
which are likely to influence the industrys
growth prospects over the next six
months. Identifies the major changes in customer
confidence levels in the pharmaceutical industry
over the next six months. Key Market
Issues According to pharmaceutical industry
respondents, the present economic conditions in
Africa and the Middle East are deemed to be
unfavourable. In the Q4 2013 survey, similar
opinions were recorded. New government
proposals/legislation, competition from new
entrants, state of global economy, and
performance of the Eurozone are the key concerns
among global pharmaceutical industry
executives. Survey respondents forecast that
supplier prices for raw materials will increase
at an average of 4.1, with those from
Asia-Pacific expecting the biggest rise. In
total, 52 of global pharmaceutical industry
executives anticipate either no change or a
negative change in customer confidence over the
industry, in the next six months. Industry
executives exhibit high levels of optimism
towards company growth prospects compared to
industry growth prospects, in the next six
months Complete report is available _at_
http//www.reportsnreports.com/reports/274168-phar
maceutical-business-confidence-report-q1-2014.html
.
Browse more research reports on
Pharmaceuticals_at_ http//www.reportsnreports.com/ma
rket-research/pharmaceuticals/ .
5
Pharmaceutical Business Confidence Report Q1 2014
Key Highlights Of respondents, 66 anticipate a
positive change in the global economic outlook
over the next six months. In comparison to
previous quarter, the percentage of respondents
who expect a positive change has increased by
eighteen percentage points. Pharmaceutical
industry executives plan to increase investments
in the areas of new product development and
marketing in the next six months. Executives
operating in the Rest of the World and
Asia-pacific anticipate the highest average sales
increase of 6.4 and 4.5, respectively, over the
next six months. Industry executives operating in
the Rest of the World and Europe anticipate an
average increase of 3.2 and 2.2, respectively,
in their current workforce. Executives operating
across the globe consider increasing sales,
improving operational efficiency, and customer
retention as key priorities over the next six
months. Buy a copy of report _at_ http//www.reportsn
reports.com/purchase.aspx?name274168
. Contact sales_at_reportsandreports.com / Call 1
888 391 5441 for further information on
Pharmaceutical Business Confidence Report Q1
2014 report OR for any other market research and
intelligence needs you may have for your
business.
Browse more research reports on
Pharmaceuticals_at_ http//www.reportsnreports.com/ma
rket-research/pharmaceuticals/ .
6
About ReportsnReports
ReportsnReports.com is your single source for all
market research needs. Our database includes
250,000 syndicated market research reports from
100 leading global publishers covering in-depth
analysis of over 5000 micro markets. With
comprehensive information about the publishers
and their report methodology, data sources, etc.
we help you in your purchase decision by mapping
your information needs with the most relevant
available reports in our library. Connect with
us sales_at_reportsandreports.com 1 888 391 5441
Contact sales_at_reportsandreports.com for further
information.
Contact sales_at_reportsandreports.com for further
information.